Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00634426
Other study ID # 1011
Secondary ID
Status Completed
Phase Phase 4
First received March 3, 2008
Last updated May 19, 2015
Start date March 2008
Est. completion date March 2013

Study information

Verified date March 2015
Source AOSpine North America Research Network
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The aim of this trial is to evaluate the differences in pain relief, neurological function, quality of life and survival in patients with metastatic epidural spinal cord compression (MESCC) who are managed with a combination of surgery and radiotherapy versus radiotherapy alone.

Further we shall evaluate cost-effectiveness of the two treatment approaches.


Recruitment information / eligibility

Status Completed
Enrollment 163
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Single symptomatic metastatic epidural spinal compression at any level confirmed by MRI

- Age 18 and more

- Able and willing to give written informed consent to participate in the study

- Able to read and write English on an elementary level

Exclusion Criteria:

- Multiple symptomatic spinal metastases

- Radiosensitive tumors

- Radioresistant tumors

- Primary cancer site in CNS or spine

- Poor life expectancy (< 3 months)

- Patients with a tumor that has compressed only the cauda equina or spinal roots

- Has a recent history of substance abuse

- Is a prisoner

- Currently involved in another study

- has a disease or condition that would preclude accurate evaluation

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Surgical excision of the metastatic process
Surgical excision of the metastatic process
Radiation:
Radiotherapy of the metastatic spine process
Standard of care radiotherapy for patients with metastatic epidural spinal cord compression.

Locations

Country Name City State
Canada Sunnybrook Health Sciences Center Toronto Ontario
Canada University of Toronto Toronto Ontario
Canada University of British Columbia Vancouver British Columbia
United States Johns Hopkins University Baltimore Maryland
United States University of Texas Hospital / MD Anderson Cancer Center Houston Texas
United States University of Kansas Medical Center Kansas City Kansas
United States West Viginia University Morgantown West Virginia
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Thomas Jefferson University and The Rothman Institute Philadelphia Pennsylvania
United States Mayo Clinic Rochester Minnesota

Sponsors (2)

Lead Sponsor Collaborator
AOSpine North America Research Network AOSpine North America

Countries where clinical trial is conducted

United States,  Canada, 

References & Publications (5)

Fisher CG, Schouten R, Versteeg AL, Boriani S, Varga PP, Rhines LD, Kawahara N, Fourney D, Weir L, Reynolds JJ, Sahgal A, Fehlings MG, Gokaslan ZL. Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of — View Citation

Fisher CG, Versteeg AL, Schouten R, Boriani S, Varga PP, Rhines LD, Heran MK, Kawahara N, Fourney D, Reynolds JJ, Fehlings MG, Gokaslan ZL. Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary t — View Citation

Fitzpatrick D, Grabarz D, Wang L, Bezjak A, Fehlings MG, Fosker C, Rampersaud R, Wong RK. How effective is a virtual consultation process in facilitating multidisciplinary decision-making for malignant epidural spinal cord compression? Int J Radiat Oncol — View Citation

Furlan JC, Chan KK, Sandoval GA, Lam KC, Klinger CA, Patchell RA, Laporte A, Fehlings MG. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis. Neuro Oncol. 2012 May;14(5):631-40. doi: 10.1093/neuonc/nos062. Epub 2012 Apr 14. — View Citation

Sciubba DM, Petteys RJ, Dekutoski MB, Fisher CG, Fehlings MG, Ondra SL, Rhines LD, Gokaslan ZL. Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine. 2010 Jul;13(1):94-108. doi: 10.3171/2010.3.SPINE09202. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in spine-associated pain intensity (BPI) measured by Brief Pain Inventory 6 weeks / 3, 6, 9, 12, 18, 24 months No
Primary Neurological outcomes measured by American Spinal Injury Association (ASIA) Motor Scale structured clinical examination 24 months No
Secondary Survival 24 months No
Secondary SF-36 v2 24 month No
Secondary EQ-5D 24 months No
Secondary Oswestry Disability Index (ODI) 24 months No
Secondary Caregiver Activity Survey 24 months No
Secondary Adverse events 24 months Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06077071 - MRIdian "RADAR" Trial N/A
Completed NCT02189473 - Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression N/A
Active, not recruiting NCT01254903 - Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC) Phase 1
Completed NCT01256554 - Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression Phase 1